CJC-1295 vs Sermorelin
CJC-1295 and Sermorelin are both peptide compounds evaluated on Vial: CJC-1295 is restricted with clinical-trial evidence, and Sermorelin is legally compoundable with clinical-trial evidence, offered by 17 and 27 verified providers respectively.
Vial summary · compiled from public records
At a glance
Sermorelin
- Category
- Peptide
- FDA / legal status
- Legally Compoundable
- Route
- Subcutaneous
Side by side
| Field | CJC-1295 | Sermorelin |
|---|---|---|
| Category | Peptide | Peptide |
| Brand names | — | — |
| FDA / legal status | Restricted | Legally Compoundable |
| Evidence tier | Clinical Trials | Clinical Trials |
| Administration route | Subcutaneous | Subcutaneous |
| Compounding access | Restricted | Legally Compoundable |
| Providers on Vial | 17 listed | 27 listed |
| Typical price band | $$ to $$$ | $$ to $$$ |
Verified providers offering each
Ranked by Vial Score, Vial’s 0 to 100 score built from federal and state public records. The score evaluates the provider, not the compound.
About each compound
About CJC-1295
A synthetic analog of growth hormone-releasing hormone (GHRH), this 30-amino acid peptide is modified with a drug affinity complex (DAC) that extends its half-life by binding to serum albumin. It stimulates pulsatile growth hormone secretion from the anterior pituitary by activating GHRH receptors. The compound has been investigated in clinical research for growth hormone deficiency and conditions associated with impaired GH/IGF-1 axis function.
About Sermorelin
A synthetic analog of growth hormone-releasing hormone (GHRH), this 29-amino acid peptide stimulates the pituitary gland to produce and secrete endogenous growth hormone through binding to GHRH receptors. It functions by mimicking the N-terminal bioactive portion of native GHRH, promoting pulsatile GH release while preserving the body's natural feedback mechanisms. Primary applications include diagnostic testing of pituitary function and therapeutic use in growth hormone deficiency.
Descriptions compiled from public FDA records and manufacturer labeling where available. Not medical advice.
This page evaluates compliance signals, not clinical outcomes. Consult a licensed physician before starting any therapy, medication, or treatment. Vial does not provide medical advice.
Related compound comparisons
Other comparisons in the same category.